FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312019237> ?p ?o ?g. }

• W4312019237 abstract "Antibody persistence and safety up to 12 months of heterologous orally administered adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in individuals who were primed with two-dose inactivated SARS-CoV-2 vaccine (CoronaVac) previously, has not been reported yet. This randomized, open-label, single-centre trial included Chinese adults who have received two-dose CoronaVac randomized to low-dose or high-dose aerosolised Ad5-nCoV group, or CoronaVac group. In this report, we mainly evaluated the geometric mean titres (GMTs) of neutralizing antibodies (NAbs) against live wild-type SARS-CoV-2 virus and omicron BA.4/5 pseudovirus at 12 months after the booster dose and the incidence of serious adverse events (SAEs) till month 12. Of 419 participants, all were included in the safety analysis and 120 (28.64%) were included in the immunogenicity analysis. Serum NAb GMT against live wild-type SARS-CoV-2 was 204.36 (95% CI 152.91, 273.14) in the low-dose group and 171.38 (95% CI 121.27, 242.19) in the high-dose group at month 12, significantly higher than the GMT in the CoronaVac group (8.00 [95% CI 4.22, 15.17], p < 0.0001). Serum NAb GMT against omicron BA.4/5 pseudovirus was 40.97 (95% CI 30.15, 55.67) in the low-dose group and 35.08 (95% CI 26.31, 46.77) in the high-dose group at month 12, whereas the GMT in the CoronaVac group was below the lower limit of detection. No vaccine-related SAEs were observed. Orally administered aerosolised Ad5-nCoV following two-dose CoronaVac priming has a good safety profile and is persistently more immunogenic than three-dose CoronaVac within 12 months after the booster dose.Trial registration: ClinicalTrials.gov identifier: NCT05043259.." @default.
• W4312019237 created "2023-01-03" @default.
• W4312019237 creator A5003217623 @default.
• W4312019237 creator A5016125800 @default.
• W4312019237 creator A5017541508 @default.
• W4312019237 creator A5020127926 @default.
• W4312019237 creator A5028939852 @default.
• W4312019237 creator A5029993919 @default.
• W4312019237 creator A5038863647 @default.
• W4312019237 creator A5043379267 @default.
• W4312019237 creator A5046212412 @default.
• W4312019237 creator A5049507373 @default.
• W4312019237 creator A5052520398 @default.
• W4312019237 creator A5056814705 @default.
• W4312019237 creator A5057822709 @default.
• W4312019237 creator A5058066961 @default.
• W4312019237 creator A5058131596 @default.
• W4312019237 creator A5060962650 @default.
• W4312019237 creator A5063812564 @default.
• W4312019237 creator A5065172118 @default.
• W4312019237 creator A5067246705 @default.
• W4312019237 creator A5070493054 @default.
• W4312019237 creator A5072289684 @default.
• W4312019237 creator A5077645027 @default.
• W4312019237 creator A5084736096 @default.
• W4312019237 date "2022-12-15" @default.
• W4312019237 modified "2023-10-14" @default.
• W4312019237 title "Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial" @default.
• W4312019237 cites W2590826851 @default.
• W4312019237 cites W3140226555 @default.
• W4312019237 cites W3142193311 @default.
• W4312019237 cites W3153879585 @default.
• W4312019237 cites W3163785571 @default.
• W4312019237 cites W3169799087 @default.
• W4312019237 cites W3177895433 @default.
• W4312019237 cites W3199394856 @default.
• W4312019237 cites W3200627491 @default.
• W4312019237 cites W3205831647 @default.
• W4312019237 cites W3209947664 @default.
• W4312019237 cites W3215964500 @default.
• W4312019237 cites W3217661335 @default.
• W4312019237 cites W4206906464 @default.
• W4312019237 cites W4210261834 @default.
• W4312019237 cites W4220943888 @default.
• W4312019237 cites W4221072241 @default.
• W4312019237 cites W4225726091 @default.
• W4312019237 cites W4226073790 @default.
• W4312019237 cites W4281720894 @default.
• W4312019237 cites W4282928458 @default.
• W4312019237 cites W4295788712 @default.
• W4312019237 cites W4309047005 @default.
• W4312019237 doi "https://doi.org/10.1080/22221751.2022.2155251" @default.
• W4312019237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36503413" @default.
• W4312019237 hasPublicationYear "2022" @default.
• W4312019237 type Work @default.
• W4312019237 citedByCount "10" @default.
• W4312019237 countsByYear W43120192372022 @default.
• W4312019237 countsByYear W43120192372023 @default.
• W4312019237 crossrefType "journal-article" @default.
• W4312019237 hasAuthorship W4312019237A5003217623 @default.
• W4312019237 hasAuthorship W4312019237A5016125800 @default.
• W4312019237 hasAuthorship W4312019237A5017541508 @default.
• W4312019237 hasAuthorship W4312019237A5020127926 @default.
• W4312019237 hasAuthorship W4312019237A5028939852 @default.
• W4312019237 hasAuthorship W4312019237A5029993919 @default.
• W4312019237 hasAuthorship W4312019237A5038863647 @default.
• W4312019237 hasAuthorship W4312019237A5043379267 @default.
• W4312019237 hasAuthorship W4312019237A5046212412 @default.
• W4312019237 hasAuthorship W4312019237A5049507373 @default.
• W4312019237 hasAuthorship W4312019237A5052520398 @default.
• W4312019237 hasAuthorship W4312019237A5056814705 @default.
• W4312019237 hasAuthorship W4312019237A5057822709 @default.
• W4312019237 hasAuthorship W4312019237A5058066961 @default.
• W4312019237 hasAuthorship W4312019237A5058131596 @default.
• W4312019237 hasAuthorship W4312019237A5060962650 @default.
• W4312019237 hasAuthorship W4312019237A5063812564 @default.
• W4312019237 hasAuthorship W4312019237A5065172118 @default.
• W4312019237 hasAuthorship W4312019237A5067246705 @default.
• W4312019237 hasAuthorship W4312019237A5070493054 @default.
• W4312019237 hasAuthorship W4312019237A5072289684 @default.
• W4312019237 hasAuthorship W4312019237A5077645027 @default.
• W4312019237 hasAuthorship W4312019237A5084736096 @default.
• W4312019237 hasBestOaLocation W43120192371 @default.
• W4312019237 hasConcept C120665830 @default.
• W4312019237 hasConcept C121332964 @default.
• W4312019237 hasConcept C126322002 @default.
• W4312019237 hasConcept C159047783 @default.
• W4312019237 hasConcept C159654299 @default.
• W4312019237 hasConcept C168563851 @default.
• W4312019237 hasConcept C197934379 @default.
• W4312019237 hasConcept C203014093 @default.
• W4312019237 hasConcept C2779261636 @default.
• W4312019237 hasConcept C2780868878 @default.
• W4312019237 hasConcept C32611913 @default.
• W4312019237 hasConcept C61511704 @default.
• W4312019237 hasConcept C71924100 @default.
• W4312019237 hasConcept C90924648 @default.
• W4312019237 hasConceptScore W4312019237C120665830 @default.
• W4312019237 hasConceptScore W4312019237C121332964 @default.
• W4312019237 hasConceptScore W4312019237C126322002 @default.

• next